Skip to content

Psychedelic-assisted therapy: all studies

Page 222 of 294: studies 2,211 to 2,220 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

The Intersection of Psychedelics and Neuroplasticity: Rethinking Therapeutic Approaches for Mental Health

Journal of Addiction & Addictive Disorders July 17, 2023 Kargbo Rb

The expanding field of psychedelic-assisted therapy presents innovative treatment avenues for various mental health disorders. This review explores the potential role of psychedelics in enhancing neuroplasticity, a key mechanism underlying recovery from mental health conditions.

A multidisciplinary approach to Mental Health and Consciousness Studies

Zenodo (CERN European Organization for Nuclear Research) July 13, 2023 Diego Gonzalez-Rodriguez 1 citation preprint

This is an introductory article to the issue titled "Integrative Psychotherapy and Non-Ordinary States of Consciousness", developed with the intention of disseminating scientific knowledge on the field of human consciousness and its potential applications in mental health. For this issue, we have gathered experts from the fields of psychedelic-assisted therapy, neuroscience, psychology, and...

Using psychedelics to mitigate Treatment Resistant Depression

Open Access Government July 13, 2023 Cosmo Feilding-Mellen

Using psychedelics to mitigate Treatment Resistant Depression Cosmo Feilding-Mellen, CEO, Beckley Psytech, charts the role of psychedelics in mitigating Treatment Resistant Depression. When it comes to treating neuropsychiatric and mental health conditions, we have to accept that one size does not fit all. For some, talking therapies like cognitive behavioural therapy plus antidepressants like...

Outcomes of usage of psychedelics by people reporting an eating disorder in clinical and non-clinical settings: a scoping review

Advances in Mental Health July 13, 2023 Jorge Valdiviezo‐oña, Lizbeth Toscano-Molina, Juan Fernando Chávez et al. 4 citations

Objective To map the studies reporting the use of psychedelics in clinical and non-clinical settings by people reporting an eating disorder (ED) and their outcomes.Method To be included, peer-reviewed articles had to be written in English or Spanish and had to address the usage of psychedelics by people reporting an ED. Searches were conducted on PubMed, Scopus, and Web of Science. Data on key...

Psychedelic therapies: The case for a new focus in the EU’s mental health care approach

Open Access Government July 10, 2023 Tadeusz Hawrot

Tadeusz Hawrot, Founder and Executive Director of PAREA, states the case for a new focus in the EU’s mental health care approach, that is the underserved area of psychedelic therapies. As we navigate deeper into the 21st century, the importance of mental health care is gaining increasing recognition. But we still have a long way to go. The OECD estimates that mental illness affects one in two...

Leveraging psychedelic therapies for binge eating disorder

Open Access Government July 10, 2023 Jim Gilligan

Leveraging psychedelic therapies for binge eating disorder Here Tryp Therapeutics examine the viability of using psychedelic therapies for Binge Eating Disorder and the potential results that using psychedelic-assisted psychotherapy could have on different eating disorders. Tryp Therapeutics is a clinical-stage biotechnology company dedicated to the development of exclusive and innovative...

[Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models].

Vertex Revista Argentina de Psiquiatría July 10, 2023 Tamara Chernoff, Bruno Kliger, Dante Hernán Venturini

Traditional psychedelics, such as LSD, psilocybin, or DMT, are psychoactive compounds that exert their effects mainly through agonism over serotonergic receptors. In appropriate doses and contexts, they produce profound changes in the subjective experience, configuring altered states of consciousness that, upon reaching a critical point, involve the appearance of phenomena of mystical,...

Psychoactive substances in psychotherapy - A vision for the future? – A systematic review on Psilocybin

July 6, 2023 Jenny Tetem, Tamara Fischmann, Tim Julian Möller preprint

This work is a literature review on the use of psilocybin in psychotherapeutic treatment of mental illnesses. The review answers the question of what opportunities and risks are associated with the use of the psychoactive substance psilocybin. Peer-reviewed studies between 2017 and 2022 were included. Nine studies were found regarding the following indications: tobacco addiction, anxiety and...

Introduction to the chemistry and pharmacology of psychedelic drugs

Australian Journal of Chemistry July 4, 2023 Scott R. Walker, Glenn A. Pullella, Matthew Piggott et al. 5 citations

The science of psychedelics is an intriguing, multi-disciplinary field that has recently been the subject of heightened public interest. This has mainly resulted from publicity associated with a number of high-profile investigations into psychedelic-assisted therapy for a range of difficult-to-treat mental health conditions. With many psychedelic substances known, including natural,...